New Amsterdam Partners’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,539
Closed -$616K 135
2017
Q4
$616K Sell
5,539
-41,352
-88% -$4.45M 0.12% 91
2017
Q3
$4.69M Sell
46,891
-4,046
-8% -$415K 0.98% 42
2017
Q2
$5.26M Sell
50,937
-881
-2% -$84.9K 1.12% 37
2017
Q1
$4.72M Sell
51,818
-11,515
-18% -$960K 1.12% 43
2016
Q4
$4.99M Sell
63,333
-10,125
-14% -$819K 1.13% 36
2016
Q3
$6.41M Sell
73,458
-4,526
-6% -$369K 1.47% 20
2016
Q2
$5.62M Sell
77,984
-159,954
-67% -$11.6M 1.37% 24
2016
Q1
$16.7M Buy
237,938
+50,758
+27% +$3.45M 1.75% 24
2015
Q4
$13.3M Buy
187,180
+13,117
+8% +$906K 1.37% 34
2015
Q3
$11.3M Buy
174,063
+15,015
+9% +$1.1M 1.14% 38
2015
Q2
$11.8M Buy
159,048
+13,873
+10% +$1.09M 1.01% 40
2015
Q1
$12M Sell
145,175
-35,125
-19% -$2.82M 0.97% 41
2014
Q4
$13.7M Sell
180,300
-4,117
-2% -$306K 1.19% 38
2014
Q3
$13M Buy
184,417
+91,070
+98% +$6.71M 0.87% 48
2014
Q2
$6.81M Buy
+93,347
New +$6.71M 0.44% 55

Other funds holding VAR

New Amsterdam Partners's VAR Position: Q1 2018 in Review

New Amsterdam Partners sold out of Varian Medical Systems, Inc. (VAR) in Q1 2018, closing a stake of 5,539 shares — an estimated $616K sold.

New Amsterdam Partners first reported a position in VAR in Q2 2014 and held it in 15 quarters. The position peaked at $16.7M in Q1 2016. 584 funds tracked by Wall St. Rank hold VAR as of Q1 2018.

  • New Amsterdam Partners reported no remaining Varian Medical Systems, Inc. position as of Q1 2018 after selling out during the quarter.
  • New Amsterdam Partners sold 5,539 Varian Medical Systems, Inc. shares in Q1 2018, an estimated $616K.
  • New Amsterdam Partners first reported a position in Varian Medical Systems, Inc. in Q2 2014 and held it in 15 quarters.
  • New Amsterdam Partners's Varian Medical Systems, Inc. position peaked at $16.7M in Q1 2016.
  • 584 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q1 2018.

Based on New Amsterdam Partners's 13F filing for Q1 2018, filed 7 May 2018.